Amy Guzik to Tissue Plasminogen Activator
This is a "connection" page, showing publications Amy Guzik has written about Tissue Plasminogen Activator.
Connection Strength
0.273
-
Chee B, Raman R, Ernstrom K, Guzik AK, Hemmen TM, Rapp KS, Meyer BC, Meyer DM. Does symptom onset to primary stroke center time goals affect stroke outcome? J Stroke Cerebrovasc Dis. 2014 May-Jun; 23(5):993-1000.
Score: 0.112
-
Saposnik G, Guzik AK, Reeves M, Ovbiagele B, Johnston SC. Stroke Prognostication using Age and NIH Stroke Scale: SPAN-100. Neurology. 2013 Jan 01; 80(1):21-8.
Score: 0.105
-
De Los Rios F, Kleindorfer DO, Guzik A, Ortega-Gutierrez S, Sangha N, Kumar G, Grotta JC, Lee JM, Meyer BC, Schwamm LH, Khatri P. Intravenous fibrinolysis eligibility: a survey of stroke clinicians' practice patterns and review of the literature. J Stroke Cerebrovasc Dis. 2014 Sep; 23(8):2130-2138.
Score: 0.030
-
Spokoyny I, Raman R, Ernstrom K, Demaerschalk BM, Lyden PD, Hemmen TM, Guzik AK, Chen JY, Meyer BC. Pooled assessment of computed tomography interpretation by vascular neurologists in the STRokE DOC telestroke network. J Stroke Cerebrovasc Dis. 2014 Mar; 23(3):511-5.
Score: 0.027